(Press-News.org) DENVER, March 24, 2015 -- A new weapon in the war against type 2 diabetes is coming in an unexpected form: fat. Researchers have discovered a new class of potentially therapeutic lipids, called fatty-acid esters of hydroxy fatty acids (FAHFAs). These lipids are found at lower levels in people with insulin resistance, a risk factor for type 2 diabetes, compared with those who don't have the condition. Administering FAHFAs to diabetic mice improved their glucose metabolism and insulin secretion, opening a surprising avenue for the development of novel medications for the disease.
The team will describe their approach in one of nearly 11,000 presentations at the 249th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society, taking place here through Thursday.
One in ten people in the United States has type 2 diabetes, which is the seventh leading cause of death. Excess weight and body fat increase disease risk. Genes also play a role, but much remains unknown.
"There are some drugs available for treating type 2 diabetes, but there are still gaps in our knowledge about what causes it," says Alan Saghatelian, Ph.D., who is at the Salk Institute for Biological Studies. He co-led the study with Barbara Kahn, M.D. "Our discovery came out of basic research to understand the mechanism underlying type 2 diabetes."
The researchers had been studying insulin resistance, a metabolic defect believed to contribute to the development and progression of type 2 diabetes. Insulin resistance occurs when the body does not respond to the insulin being produced, causing glucose to build up in the blood. It is typically associated with obesity. But Kahn's team at Beth Israel Medical Deaconess Center found that they could create obese mice that were unusually sensitive to insulin.
As it turned out, these mice had levels of a previously undiscovered family of fats, which they named FAHFAs, that was massively elevated --16- to 18-fold. The researchers suspected that these lipids were behind the increased insulin sensitivity. They figured if that were the case, then research on these newly discovered fats could someday lead to a diabetes therapy. In total, the researchers identified 16 different types of FAHFAs in the mice using a technique called mass spectrometry.
To check that their findings weren't limited to rodents, the researchers measured FAHFA levels in the blood samples from human subjects, finding lower levels of these compounds in those with insulin resistance. They also checked various foods and detected FAHFAs in many common items, such as apples, broccoli, beef, chicken and eggs. "We've been eating them for a long time, and they aren't toxic," says Saghatelian, suggesting FAHFAs may be safe to use as a medication.
To test how well FAHFAs could work as a potential therapy, the researchers fed the lipids to insulin- resistant mice, and observed an improvement in inflammation, insulin sensitivity and glucose uptake. Although this experiment suggests that FAHFAs may make good type-2-diabetes drugs, Saghatelian says he's now looking beyond lipids. "These are very cool compounds, but lipids aren't typically used as drugs for several reasons, including that they might not be able to reach effective doses in the relevant tissues," he says. "But the existence of FAHFAs means there is a metabolic pathway for making and breaking down these molecules. Identifying the enzymes involved in those processes may provide a lead toward even better drug targets."
The Saghatelian and Kahn laboratories are currently parsing human tissues for those that show increasing or decreasing levels of FAHFAs. Once identified, the scientists will search the tissue for enzymes involved in FAHFA metabolism. Drugs could potentially be developed that work by either increasing the activity of enzymes that produce FAHFAs or blocking those that destroy FAHFAs.
"As we learn more about type 2 diabetes," says Saghatelian, "we may be able to come up with better therapies that treat the disease with fewer side effects and that are effective in a larger number of people."
A press conference on this topic will be held Tuesday, March 24, at 2 p.m. Mountain time in the Colorado Convention Center. Reporters may check-in at Room 104 in person, or watch live on YouTube http://bit.ly/ACSLiveDenver. To ask questions, sign in with a Google account.
INFORMATION:
Kahn and Saghatelian acknowledge funding from the National Institutes of Health, Searle Scholars Award, Burroughs Welcome Fund, a Sloan Research Fellowship and JPB foundation.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 158,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Note to journalists: Please report that this research is being presented at a meeting of the American Chemical Society.
Follow us: Twitter | Facebook
Title
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects
Abstract
Increased adipose tissue lipogenesis is associated with enhanced insulin sensitivity. Mice overexpressing the Glut4 glucose transporter in adipocytes have elevated lipogenesis and increased glucose tolerance despite being obese with elevated circulating fatty acids. Lipidomic analysis of adipose tissue revealed the existence of branched fatty acid esters of hydroxy fatty acids (FAHFAs) that were elevated 16- to 18-fold in these mice. FAHFA isomers differ by the branched ester position on the hydroxy fatty acid (e.g., palmitic-acid-9-hydroxy-stearic-acid, 9-PAHSA). PAHSAs are synthesized in vivo and regulated by fasting and high-fat feeding. PAHSA levels correlate highly with insulin sensitivity and are reduced in adipose tissue and serum of insulin-resistant humans. PAHSA administration in mice lowers ambient glycemia and improves glucose tolerance while stimulating GLP-1 and insulin secretion. PAHSAs also reduce adipose tissue inflammation. In adipocytes, PAHSAs signal through GPR120 to enhance insulin-stimulated glucose uptake. Thus, FAHFAs are endogenous lipids with the potential to treat type 2 diabetes.
DENVER, March 24, 2015 -- The recent increase in natural gas production could provide a bridge to a lower carbon future because it generates half the carbon dioxide (CO2) of coal when burned. However, natural gas that is leaked into the atmosphere could speed global warming and climate change. That's because its primary component, methane, is a much more powerful greenhouse gas than CO2. Understanding the leakage rate is critical to assessing the environmental benefit of natural gas, but there is much controversy, debate and confusion among scientists and policy-makers ...
LAS VEGAS--Osteoporosis is a disease of progressive bone loss affecting more than 44 million Americans and contributing to an estimated 2 million bone fractures each year. A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that routine bisphosphonate treatment of women over 65 who sustain a distal radius (wrist) fracture--one of the most common fractures associated with osteoporosis--could significantly reduce the risk for additional fractures, primarily hip fractures, but at an estimated cost of more than ...
LAS VEGAS--New research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that most child pedestrian injuries involving a motor vehicle occurred while children were unsupervised, near schools and bus stops, and in the spring months during the afternoon and evening hours.
Pedestrian injuries are among the leading causes of pediatric deaths in the U.S. In 2012, 557 child and young adult pedestrians under age 20 were killed by motor vehicles in the U.S. and 22,000 were injured, according to the National Highway Traffic ...
LAS VEGAS--Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Each year, more than 322,000 patients undergo hip replacement surgery in the U.S. Previous studies, conducted more than a decade ago, recommended between six and eight weeks of recovery before driving; however, recent advances in surgical treatment ...
LAS VEGAS--Diabetes and previous joint pain, along with a patient's overall physical health status, may predicts arthritis pain with nearly 100 percent accuracy, in new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
An estimated one out of five adults is living with an arthritis diagnosis, according to the U.S. Centers for Disease Control and Prevention (CDC), and the number is expected to rise from 52.5 to 67 million by 2030. Arthritis means "inflammation of a joint." In osteoarthritis, the most common type ...
LAS VEGAS--Chronic low back pain can limit everyday activities, including sex. New research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), found that 70 percent of patients consider sexual activity "relevant" to their life quality, and patients who receive surgical treatment for spinal spondylolisthesis (DS) and spinal stenosis (SS)--common degenerative conditions most often occurring in older adults--were twice as likely to report no pain during sex.
"Our current research sheds light on the effect that spinal surgery ...
LAS VEGAS--While men and women have similar levels of improvement following total knee replacement (TKR) surgery, men have higher levels of function before and after TKR, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
According to the Agency for Healthcare Research and Quality, more than 600,000 knee replacements are performed in the U.S. each year. In 2012, 393,345 women and 237,896 men underwent TKR, most often to alleviate the pain and immobility associated with late-stage arthritis. While ...
LAS VEGAS--In recent years there has been an explosion in barefoot running, as well as the purchase and use of "minimalist" running shoes that more closely resemble barefoot running by encouraging the balls of the feet, between the arch and toes, to hit the pavement first. A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), found that a significant number of experienced runners, age 30 and older (40 percent of men and 20 percent of women), maintained a heel-first running pattern--which naturally occurs when wearing ...
LAS VEGAS--Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Each year, more than 322,000 patients undergo hip replacement surgery in the U.S. Previous studies, conducted more than a decade ago, recommended between six and eight weeks of recovery before driving; however, recent advances in surgical treatment ...
LAS VEGAS -- A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that 48 percent of hip fracture patients, age 65 and older, had delirium, or acute confusion, before, during and after surgery (perioperative), resulting in significantly longer hospital stays and higher costs for care.
Approximately 300,000 Americans are hospitalized with hip fractures each year. The risk is particularly high in post-menopausal women who face an increased risk for osteoporosis, a disease that diminishes bone mass and increases ...
